ATE75396T1 - Verwendung von kojic-saeure oder ihres betacyclodextrin-einschlusskomplexes zur praevention von elastosis. - Google Patents
Verwendung von kojic-saeure oder ihres betacyclodextrin-einschlusskomplexes zur praevention von elastosis.Info
- Publication number
- ATE75396T1 ATE75396T1 AT86108952T AT86108952T ATE75396T1 AT E75396 T1 ATE75396 T1 AT E75396T1 AT 86108952 T AT86108952 T AT 86108952T AT 86108952 T AT86108952 T AT 86108952T AT E75396 T1 ATE75396 T1 AT E75396T1
- Authority
- AT
- Austria
- Prior art keywords
- kojic acid
- elastosis
- inclusion complex
- drugs
- prevention
- Prior art date
Links
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004705 kojic acid Drugs 0.000 title abstract 3
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 title abstract 3
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 239000001116 FEMA 4028 Substances 0.000 title abstract 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 title abstract 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 title abstract 2
- 229960004853 betadex Drugs 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000700159 Rattus Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 238000005562 fading Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Electroluminescent Light Sources (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60146029A JPH0613448B2 (ja) | 1985-07-02 | 1985-07-02 | 皮膚弾力線維症予防剤 |
| EP86108952A EP0207499B1 (de) | 1985-07-02 | 1986-07-01 | Verwendung von Kojic-Säure oder ihres beta-Cyclodextrin-Einschlusskomplexes zur Prävention von Elastosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE75396T1 true ATE75396T1 (de) | 1992-05-15 |
Family
ID=15398494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86108952T ATE75396T1 (de) | 1985-07-02 | 1986-07-01 | Verwendung von kojic-saeure oder ihres betacyclodextrin-einschlusskomplexes zur praevention von elastosis. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4891361A (de) |
| EP (1) | EP0207499B1 (de) |
| JP (1) | JPH0613448B2 (de) |
| KR (1) | KR890004556B1 (de) |
| AT (1) | ATE75396T1 (de) |
| AU (1) | AU591680B2 (de) |
| CA (1) | CA1282332C (de) |
| DE (1) | DE3685060D1 (de) |
| DK (1) | DK166429B1 (de) |
| FI (1) | FI862806A0 (de) |
| GR (1) | GR861671B (de) |
| HK (1) | HK51594A (de) |
| IE (1) | IE59082B1 (de) |
| IN (1) | IN165985B (de) |
| PH (1) | PH22349A (de) |
| PT (1) | PT82889B (de) |
| ZA (1) | ZA864166B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2809429B2 (ja) * | 1989-05-26 | 1998-10-08 | 湧永製薬株式会社 | 制ガン剤ならびに制ガン剤として有用な新規複素環化合物またはそれらの塩 |
| JPH04298437A (ja) * | 1991-03-26 | 1992-10-22 | Fuji Photo Film Co Ltd | 画像形成装置 |
| US5296472A (en) * | 1991-12-05 | 1994-03-22 | Vyrex Corporation | Methods for delipidation of skin and cerumen removal |
| JP3566739B2 (ja) * | 1993-09-30 | 2004-09-15 | 三省製薬株式会社 | 皮膚外用剤の安定化方法 |
| US5874463A (en) | 1994-10-24 | 1999-02-23 | Ancira; Margaret | Hydroxy-kojic acid skin peel |
| US6596263B1 (en) * | 1995-07-14 | 2003-07-22 | Stc English Ideas, Inc. | Cyclodextrin compositions |
| GB2307176A (en) * | 1995-11-15 | 1997-05-21 | Todd Selwyn Everest | Anti-inflammatory clathrating agents for topical use |
| KR100471372B1 (ko) * | 2001-12-04 | 2005-03-08 | 주식회사 태평양 | 피부 탄력 향상용 화장료 조성물 |
| US20040126339A1 (en) * | 2002-12-31 | 2004-07-01 | Roszell James A. | Sunscreen composition and methods for manufacturing and using a sunscreen composition |
| US20080070982A1 (en) * | 2006-09-15 | 2008-03-20 | Graham Timmins | System and methods of melanoma prevention |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS533538A (en) * | 1976-06-28 | 1978-01-13 | Sansho Seiyaku Kk | Skin bleach cosmetics |
| JPS55157509A (en) * | 1979-05-24 | 1980-12-08 | Sansho Seiyaku Kk | Ultraviolet ray intercepting agent safe to skin |
| JPS61109705A (ja) * | 1984-11-01 | 1986-05-28 | Sansho Seiyaku Kk | 色白化粧料 |
-
1985
- 1985-07-02 JP JP60146029A patent/JPH0613448B2/ja not_active Expired - Lifetime
-
1986
- 1986-06-04 ZA ZA864166A patent/ZA864166B/xx unknown
- 1986-06-04 IE IE148186A patent/IE59082B1/en not_active IP Right Cessation
- 1986-06-04 KR KR1019860004420A patent/KR890004556B1/ko not_active Expired
- 1986-06-05 CA CA000510952A patent/CA1282332C/en not_active Expired - Lifetime
- 1986-06-12 IN IN440/CAL/86A patent/IN165985B/en unknown
- 1986-06-16 AU AU58897/86A patent/AU591680B2/en not_active Expired
- 1986-06-25 PH PH33945A patent/PH22349A/en unknown
- 1986-06-26 GR GR861671A patent/GR861671B/el unknown
- 1986-07-01 DK DK313786A patent/DK166429B1/da not_active IP Right Cessation
- 1986-07-01 DE DE8686108952T patent/DE3685060D1/de not_active Expired - Lifetime
- 1986-07-01 PT PT82889A patent/PT82889B/pt not_active IP Right Cessation
- 1986-07-01 AT AT86108952T patent/ATE75396T1/de active
- 1986-07-01 FI FI862806A patent/FI862806A0/fi not_active Application Discontinuation
- 1986-07-01 EP EP86108952A patent/EP0207499B1/de not_active Expired - Lifetime
-
1988
- 1988-05-18 US US07/198,637 patent/US4891361A/en not_active Expired - Lifetime
-
1994
- 1994-05-19 HK HK51594A patent/HK51594A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI862806A0 (fi) | 1986-07-01 |
| DK313786D0 (da) | 1986-07-01 |
| GR861671B (en) | 1986-10-30 |
| IE59082B1 (en) | 1994-01-12 |
| IN165985B (de) | 1990-02-17 |
| KR870000931A (ko) | 1987-03-10 |
| JPS625909A (ja) | 1987-01-12 |
| HK51594A (en) | 1994-05-27 |
| EP0207499A3 (en) | 1989-04-26 |
| PT82889A (en) | 1986-08-01 |
| EP0207499B1 (de) | 1992-04-29 |
| US4891361A (en) | 1990-01-02 |
| AU591680B2 (en) | 1989-12-14 |
| CA1282332C (en) | 1991-04-02 |
| DK313786A (da) | 1987-01-03 |
| ZA864166B (en) | 1987-02-25 |
| PT82889B (pt) | 1988-05-27 |
| JPH0613448B2 (ja) | 1994-02-23 |
| EP0207499A2 (de) | 1987-01-07 |
| DE3685060D1 (de) | 1992-06-04 |
| IE861481L (en) | 1987-01-02 |
| AU5889786A (en) | 1987-01-08 |
| DK166429B1 (da) | 1993-05-24 |
| KR890004556B1 (ko) | 1989-11-15 |
| PH22349A (en) | 1988-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3582439D1 (de) | Mittel zur behandlung von herzerkrankungen. | |
| PT83961A (de) | Pyrazolin-derivate ihre herstellung und ihre verwendung als mittel mit insektizider und akarizider wirkung | |
| BE817108A (fr) | Compositions d'enzyme presentant une activite et une stabilite ameliorees en solution aqueuse | |
| DK206290D0 (da) | Acrylsyrederivater | |
| ATE50926T1 (de) | Auf phosphorsaeureester basierende, oberflaechenaktive zusammensetzungen, deren herstellungsverfahren und deren verwendung um wirksame praeparate herzustellen. | |
| FR2653336B1 (fr) | Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique. | |
| ATE75396T1 (de) | Verwendung von kojic-saeure oder ihres betacyclodextrin-einschlusskomplexes zur praevention von elastosis. | |
| FR2544984B1 (fr) | Pommade dermique et dermatologique a large spectre d'activite, et son procede de preparation | |
| ATE20641T1 (de) | Pharmazeutisches praeparat zur topischen behandlung von akne. | |
| ES467222A1 (es) | Procedimiento de preparacion de una emulsion del tipo agua en aceite o aceite en agua estable. | |
| ATE258440T1 (de) | Verwendung von neutralen gallium chelaten mit 3- hydroxy-4-pyrone verbindungen zur behandlung von krankheiten die verbessert werden können durch die hemmung der hyperproliferation von keratinocyten | |
| KR950014093A (ko) | 코지산 유도체 | |
| DE3650395D1 (de) | Gärung zur Gewinnung von d-Milchsäure. | |
| ATE100670T1 (de) | Pflanzenfungizide mittel enthaltend als wirstoffe salze der pyrophosphorigen saeure und ihre anwendung. | |
| DE68907386D1 (de) | Verwendung von phytinsaeure oder deren salzen zur verhinderung oder behandlung von lebererkrankungen. | |
| YU128891A (sh) | Derivati karboksimetilciklopropana | |
| DE68918280D1 (de) | Kosmetische zusammensetzung auf der basis von chromo-carboxylaten. | |
| DE3673129D1 (de) | Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel. | |
| DE3788473D1 (de) | Züchtung von Keratinozyten-Megakolonien und ihre Verwendung für Bestimmungen. | |
| JPS56147704A (en) | Dermatological composition | |
| DE3675720D1 (de) | Behandlung von material aus lignocellulose. | |
| DE68913797D1 (de) | Verwendung von Paraaminosalicylsäure zur Stabilisierung der enzymatischen Aktivität von Peroxydase in Lösung, Stabilisierungsmittel und Verwendung von stabiliserter Lösung. | |
| FI853078A7 (fi) | Askorbiinihapon ja askorbiinihappoanalogien platinakomplekseja. | |
| JPS5799516A (en) | Hair tonic | |
| DE69127618D1 (de) | Verwendung eines Wirkstoffs zur Inhibierung von Tyrosinase |